Clinical Trials Logo

NT-pro-BNP clinical trials

View clinical trials related to NT-pro-BNP.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03107390 Terminated - Clinical trials for Inflammatory Bowel Diseases

Evaluation of NT-proBNP in Chronic Inflammatory Bowel Disease

NT-pro-MICI
Start date: October 28, 2013
Phase: N/A
Study type: Interventional

NT-proBNP is a major diagnostic and prognostic marker in cardiology, but it is also a new marker for biological inflammation, especially in rheumatology. Its evaluation in chronic inflammatory bowel disease was carried out in a preliminary study, the OPERA study where in a population of 12 patients showed an increase in NT-proBNP correlated with the biological and endoscopic activity of the disease. This larger study is therefore a pilot study that could see NTproBNP as a new biomarker of inflammation in MICI.